相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Junko Ozao-Choy et al.
CANCER RESEARCH (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Phase I Trial of Sunitinib Malate plus Interferon-alpha for Patients with Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
CLINICAL GENITOURINARY CANCER (2009)
Can Tyrosine Kinase inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis
Manfred Johannsen et al.
EUROPEAN UROLOGY (2009)
Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
Madeleine M. Hipp et al.
BLOOD (2008)
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients:: CD1c+ dendritic cell frequency predicts progression-free survival
Hester van Cruijsen et al.
CLINICAL CANCER RESEARCH (2008)
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
James H. Finke et al.
CLINICAL CANCER RESEARCH (2008)
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma
John A. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Interleukin 21: combination strategies for cancer therapy
Kresten Skak et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Interleukin-21 signaling: Functions in cancer and autoimmunity
Ian D. Davis et al.
CLINICAL CANCER RESEARCH (2007)
Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration
Stefan Kuchen et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
Liang Zhou et al.
NATURE IMMUNOLOGY (2007)
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: A phase II study of the Southwest Oncology Group
Christopher W. Ryan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer
Jared A. Gollob et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn et al.
NATURE (2007)
The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Long-term outcomes in first-line patients (pts)
C. W. Ryan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I trial of sorafenib in combination with IFN α-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma
Bernard Escudier et al.
CLINICAL CANCER RESEARCH (2007)
IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production
Jonathan M. Coquet et al.
JOURNAL OF IMMUNOLOGY (2007)
被撤回的出版物: Update on the application of interleukin-2 in the treatment of renal cell carcinoma (Retracted article. See vol. 24, pg. 3783, 2018)
David F. McDermott
CLINICAL CANCER RESEARCH (2007)
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes
Ilaria Peluso et al.
JOURNAL OF IMMUNOLOGY (2007)
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
R Zeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
IL-21 induces the functional maturation of murine NK cells
J Brady et al.
JOURNAL OF IMMUNOLOGY (2004)
Cytokine-receptor pairing: Accelerating discovery of cytokine function
D Foster et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
A critical role for IL-21 in regulating immunoglobulin production
K Ozaki et al.
SCIENCE (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function
J Parrish-Novak et al.
NATURE (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
